Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 663-668, 1997;
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demacker, P. N. M.
Right arrow Articles by Baadenhuijsen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demacker, P. N. M.
Right arrow Articles by Baadenhuijsen, H.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 1997;43:663-668.)
© 1997 American Association for Clinical Chemistry, Inc.


Articles

Precipitation methods for high-density lipoprotein cholesterol measurement compared, and final evaluation under routine operating conditions of a method with a low sample-to-reagent ratio

Pierre N. M. Demacker1,a, Marja Hessels2, Helga Toenhake-Dijkstra2 and Henk Baadenhuijsen2

1 Department of Medicine, Division of General Internal Medicine, and
2 Department of Clinical Chemistry, University Hospital Nijmegen, 6500 HB Nijmegen, The Netherlands.
a Author for correspondence. Fax 0031-24-3541346.


   Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
We evaluated six precipitation methods for high-density lipoprotein cholesterol (HDL-chol) determination: the heparin/Mn2+precipitation reagent method (Hep), two variants of the phosphotungstic acid/Mg2+ method (Tung-L and Tung-B), the dextran sulfate 50 000/Mg2+ method (Dex), the PEG 6000 method (PEG), and the PEG 6000/dextran sulfate 15 000 (PEG/Dex) method. The Tung-B and PEG/Dex precipitation methods have a low sample/precipitation reagent volume ratio (<0.4). The Tung-B, Dex, PEG, and PEG/Dex methods gave similar values, averaging within 0.1 mmol/L of each other, showing that the precipitation selectivity of these methods is comparable. The precipitation efficiency of Tung-B and Peg/Dex, however, was superior. Ultrafiltration of the supernatants was needed only at triglyceride concentrations >16.4 mmol/L (undiluted sample) or >28.0 mmol/L (sample diluted twofold); however, ultrafiltration without dilution was the most accurate method. Results of Tung-B under routine conditions (33 technicians) agreed well with those of the PEG method for 406 normo- and hyperlipidemic plasma samples. By comparison with the HDL-chol method from the Centers for Disease Control and Prevention, the Tung-B method showed a total error of 10.6%, which fulfills the criteria of the National Cholesterol Education Program for HDL-chol analysis. In conclusion, with motivated personnel, Tung-B is a reliable, cost-effective method for routine HDL-chol analysis.


Key Words: indexing terms: lipoproteins • method comparison • laboratory management


   Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Proper risk estimation for coronary heart disease involves total cholesterol and high-density lipoprotein cholesterol (HDL-chol) measurements (1)(2)(3)(4).1 HDL-chol measurement is still problematic, despite the general use of a Proposed Selected Method (5), especially in samples that have been frozen and in lipemic plasma samples (6)(7). Earlier, we introduced and fully validated the polyethylene glycol (PEG) 6000 method (8). Given its excellent agreement with ultracentrifugation/heparin–Mn2+ (Hep) precipitation and its problem-free use in all our research projects in the last 15 years, the PEG 6000 method has, in our area, gradually gained the status of a "Regional Designated Comparison Method." This attainment was stimulated by its superior precipitation efficiency among all the first-generation precipitation methods (6)(9). Although the results obtained with the PEG 6000 method are scientifically reliable, the analyses must be performed by a specialized group of technicians.

Given the steady growth in the number of requests for HDL-chol determinations, we felt the need for another method, one that could be used more generally, i.e., in the routine laboratory also. For this purpose we evaluated several "first-generation" precipitation methods, including the Proposed Selected Method, which uses dextran sulfate 50 000/Mg2+ (Dex) (5). We also included two "second-generation" precipitation methods, which use a more diluted precipitation reagent to obtain more-effective precipitation. In this study we clearly show that not only methodological but also personnel aspects must be taken into account in generating the best analytical results in a routine laboratory.


   Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
procedures, part 1
In the first part of this study, the merits of six different precipitation methods were compared by a single experienced technician. The first-generation procedures used are listed here in the same order as in our previous study (9). In that study these procedures were validated and compared against an ultracentrifugation/precipitation procedure, very similar to the Centers for Disease Control and Prevention (CDC) HDL method, except that the cholesterol was determined with enzymatic analysis. In these first-generation HDL methods, the volume of serum is >5 times the volume of precipitation reagent. In Tung-B and PEG/Dex, second-generation methods, the volume of serum is <0.4 times the volume of precipitation reagent. In the first part of the study, in which only a limited number of samples were analyzed, the results were compared with consensus values, i.e., the average values obtained with four different methods that appeared to give very similar results. Assay conditions of the various precipitation methods, and of the different ways we analyzed for cholesterol, are summarized in Table 1 .


View this table:
[in this window]
[in a new window]
 
Table 1. Procedures used in the two parts of this study.

In the first part of this study, the following precipitation procedures were evaluated:

Hep [9, 10].
One milliliter of serum was mixed with 100 µL of a mixture of equal parts of 40 g/L sodium heparinate solution (156 USP units/mg; Organon, Oss, The Netherlands) and 1 mol/L MnCl2 solution. After 10 min, the samples were centrifuged for 15 min at 4000g. The supernate was aspirated as described (9) with a Pasteur pipette. When turbid, the supernatant was filtered through a 0.20-µm (average pore size) filter (FP030/3; Schleicher and Schüll, Dassel, Germany) (9). Cholesterol content was quantified with the macromethod described in Table 1Up , and the final concentration was corrected for dilution.

Tung-L method: phosphotungstate/Mg2+ [9–11].
2+ [9–11]. Optimized phosphotungstate reagent was prepared by dissolving 40 g of phosphotungstic acid (cat. no. 583; Merck, Darmstadt, Germany) in distilled water. The pH of the solution was adjusted to 6.15 with 1 mol/L NaOH (12), and the reagent was diluted to 1 L with water. The Mg2+ concentration of the 2.5 mol/L MgCl2 solution was checked by atomic absorption spectrometry (13). One milliliter of serum was mixed with 20 µL of the 2.5 mmol/L MgCl2 solution (final concentration: 1.39 µmol of phosphotungstic acid and 50 µmol of MgCl2 per milliliter of serum). After 15 min, the HDL fraction was isolated as described, and cholesterol was determined with the macromethod.

Tung-B method: phosphotungstate/Mg2+.
We also applied a second version of the phosphotungstate/Mg2+ method, using reagent from Boehringer Mannheim (Mannheim, Germany; cat. no. 543004): 200 µL of serum was mixed with 500 µL of precipitation reagent (final concentrations: 1.1 µmol of phosphotungstic acid and 50 mmol of MgCl2 per milliliter of serum). After incubation, the supernate was isolated as described above, and the cholesterol was determined with a microassay (see Table 1Up ).

Dex[5].
We used reagent obtained from Johnson & Johnson (Rochester, NY), pipetting 0.5 mL of serum into the Ektachem (Johnson & Johnson) HDL assay tube containing dextran sulfate 50 000/magnesium reagent. After incubation, we applied the conditions for fractionation and cholesterol analysis described above. One milliliter of serum was mixed with 100 µL of a mixture of equal parts of 2 mol/L MgCl2 and dextran sulfate; the HDL fraction was isolated as described and assayed for cholesterol with the macromethod.

PEG 6000
[6, 8]. One milliliter of serum was mixed with 200 µL of PEG 6000 solution [22.5 g of Merck no. 807491 and 22.5 g of Fluka (Fuchs, Switzerland) no. 81260, both dissolved in 100 mL of 0.2 mol/L Tris-HCl buffer, pH 8.2]. The final PEG 6000 concentration in serum was thus 75 g/L. After thorough vortex-mixing, incubation, and centrifugation, HDL fractions were isolated as above and were determined for cholesterol with the macromethod.

PEG/Dex [14].
The reagent, from Instruchemie (Hilverium, The Netherlands), contained 0.15 mol/L NaCl, 100 g/L PEG 6000, 37.4 mg/L dextran sulfate 15 000, and 2.6 mmol/L MgCl2. Serum (100 µL) was mixed with 1000 µL of the HDL-chol precipitation reagent. After incubation, the supernate was isolated and cholesterol was assayed with the micromethod.

Cholesterol quantification.
The cholesterol in the supernates was determined with a Multistat IL-III (Instrumentation Laboratory, Lexington, MA) centrifugal analyzer by one of two methods, depending on the final concentration of the analyte in the sample after dilution (Table 1Up ). We used the CHOD-PAP reagent (cat. no. 237574; Boehringer Mannheim). The results of both the micro- and the macro-version assays (for 1.2- and 11-fold-diluted plasma samples, respectively) showed good agreement (r = 0.999). In all measurements, the actual cholesterol concentration found for the HDL fractions was corrected for the "precipitation blank" (apparent cholesterol concentration of appropriately diluted precipitation reagent); this generally amounted to <0.03 mmol/L, except for the Hep reagent, which gave a value of 0.10–0.15 mmol/L.

Triglycerides assay.
Triglycerides were analyzed on the Hitachi 747 analyzer with reagent no. 1361155 (both from Boehringer Mannheim). We checked the method's accuracy against that of a semiautomated colorimetric method (15). Imprecision was 1.6% (n = 30) for concentrations <=12 mmol/L.

procedures, part 2
In the second part of this study, the Tung-B method was evaluated under routine conditions by 33 different technicians in the routine laboratory, the technicians having been individually instructed by the one experienced colleague who performed the first part of the study. Because of the extensive previous validation and experience with the PEG 6000 method, we used this method for comparison. Cholesterol was measured in the routine laboratory with a Hitachi 747 analyzer (using the microassay version described in Table 1Up ). As a further validation of the Tung-B method, we analyzed for 3 days in duplicate 7 fresh serum samples with HDL-chol concentrations ranging from 0.73 to 2.13 mmol/L; aliquots of these sera were also analyzed by the official CDC HDL-chol method at the Lipid Reference Laboratory (Rotterdam, The Netherlands) under the supervision of C. Cobbaert-Boersma.

specimens
Blood samples from normolipidemic subjects and from patients with various types of hyperlipoproteinemia were drawn into Vacutainer Tubes (Becton Dickinson, Rutherford, NJ). Serum was isolated within 2 h and was stored at 4 °C for no more than 2 days. In the first part of the study, 26 fresh serum samples with triglycerides <4.7 mmol/L were analyzed. In the second part, 406 sera or EDTA-containing plasma samples were analyzed (mean ± SD triglycerides 5.0 ± 6.7 mmol/L; cholesterol 7.1 ± 2.7 mmol/L).

The precipitation capacity of the various HDL-chol methods was studied in two ways. Initially, sera were analyzed after addition of increasing concentrations of saccharose (20, 75, 125, or 200 g/L) to produce samples characterized by an increase in background absorbance and a slight increase in viscosity. This addition interferes with the sedimentation of lipoproteins and mirrors the precipitation problems routinely seen in strongly lipemic sera. For more-definitive conclusions, we also compared the precipitation efficiency of the Tung-B, Dex, and PEG methods for analysis of frozen stored hypertriglyceridemic serum samples with triglycerides concentrations as great as 54.7 mmol/L (mean ± SD plasma triglycerides 18.8 ± 12.0 mmol/L; plasma cholesterol 10.6 ± 2.8 mmol/L). After centrifugation of the incubated sample/reagent mixtures under routine conditions, we analyzed whether the supernate was clear, turbid, or clear with a lipid layer at the meniscus, as a function of the serum triglyceride concentration. These precipitation methods were selected for evaluation because they show the largest range in the final background density (specific gravity) according to variations in sample/reagent ratio (Tung-B vs Dex) or the most variation in coprecipitation of proteins (PEG and Tung-B vs Dex).

Separately, 10 to 34 similarly strongly lipemic sera were analyzed with the various precipitation methods; all had a plasma triglyceride concentration >10 mmol/L, and all were analyzed both undiluted and twofold diluted with saline or with bovine serum albumin (Cohn Fraction V), 40 g/L.

statistical analysis
Results are given as mean ± SD and were analyzed by Student's paired t-test. Results obtained by different methods were correlated by use of Pearson's correlation test with the application of the SSPS/PC statistical software (version 3.1; SSPS, Chicago, lL). We also calculated the standard errors (SE) in the intercept, slope, and estimate (Sy|x), using the test of Passing and Bablock. For most intermethod comparisons, the deviations in intercept and slope did not deviate from the ideal curve y = x (16). This behavior is, therefore, not explicitly mentioned for each method in Results. Differences were considered significant if P was <0.05.


   Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Accuracy of the various precipitation methods.
After several trial sessions to become acquainted with the various precipitation procedures, the solo technician assayed 26 different sera over 2 days in the first part of this study. As in a previous evaluation in which we analyzed the samples for HDL with two different cholesterol reagents, we observed a good agreement between the results of all methods. On the basis of the previous study, we selected the PEG 6000 method as the comparison method. Evaluation of the results showed that those obtained with Tung-B, Dex, PEG 6000, and PEG/Dex methods were similar (P >0.4; intermethod CV = 3.6%). Given the relatively small number of samples analyzed, we averaged the results obtained in the Tung-B, Dex, PEG 6000, and PEG/Dex methods and used these averages as "consensus" values with which the results of all HDL methods were compared. In agreement with previous results (9), the Hep results showed a positive bias, despite the blank correction (Table 2 ).This is inherent to (typical of) interference of Mn2+ with the cholesterol assay, not an inaccuracy of the precipitation procedure. Also in agreement with the previous study (9), the Tung-L method results showed a negative bias, for unknown reasons.


View this table:
[in this window]
[in a new window]
 
Table 2. Results of 6 different HDL-chol precipitation methods compared.

Precipitation capacity of the methods.
As evaluated with the saccharose-containing samples and hypertriglyceridemic sera, both second-generation methods had the best precipitation efficiency, successfully fractionating samples with triglyceride concentrations of <16.4 to 17.6 mmol/L. The precipitation efficiency of the PEG method was slightly lower, followed in order by the Tung-L, Dex, and Hep methods. The supplier states that twofold dilution with saline enhances the precipitation efficiency. This was indeed true but gave slightly inaccurate results: 0.63 ± 0.32 mmol/L vs 0.72 ± 0.31 mmol/L in undiluted samples (n = 10, P <0.001). The difference was smaller when 60 g/L bovine serum albumin instead of saline was used as diluent for turbid samples: 0.60 ± 0.22 vs 0.64 ± 0.32 mmol/L, respectively (n = 34, P <0.001). This latter modification was indeed very effective, such that only sera with triglyceride concentrations >28.0 mmol/L needed ultrafiltration. Such samples necessarily contain chylomicrons but, by careful handling, aspiration of the flocculate at the meniscus can largely be avoided. Consequently, the obligatory ultrafiltration step is very simple to perform. Moreover, even without dilution, eventual ultrafiltration of these samples gave values similar to those obtained with the PEG method: 0.74 ± 0.28 vs 0.74 ± 0.31 mmol/L, respectively (n = 34).

Although we did not evaluate this possibility, the PEG/Dex method probably yields the lowest number of turbid supernates for these strongly lipemic samples because the samples are the most highly diluted in this method.

Imprecision of the various methods.
Three frozen stored serum samples (cholesterol <6.0 mmol/L, triglycerides <2.0 mmol/L) were analyzed with the various HDL-chol procedures by an experienced technician on 5 different days. None of these sera yielded turbid supernates. The imprecision of the various methods, expressed as SDs, ranged from 0.02 ± 0.01 mmol/L to 0.04 ± 0.01 mmol/L. Analyses of the samples containing 200 g/L saccharose with the first-generation precipitation methods frequently required ultrafiltration of the supernates. Because of the ultrafiltration step, the imprecision in these samples with either precipitation reagent was similar to the values obtained for the frozen serum pools without saccharose, except for the values obtained with the Hep method (SD 0.12 ± 0.05 mmol/L). Thus, both second-generation precipitation methods were the most efficient and resulted in the highest possible precision.

Evaluation of the Tung-B method under routine conditions.
The Tung-B method appears to be accurate and precise, and its reagent composition is simple and widely available, in contrast to the PEG/Dex reagent. Therefore, we selected the Tung-B method for future use on the routine laboratory. As a test, 33 different technicians analyzed 406 samples over 6 weeks. The results agreed well with those obtained with the PEG method, irrespective of the triglyceride concentration or any need for ultrafiltration (Fig. 1 ).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. HDL-chol values obtained with the Tung-B (y) and PEG (x) methods compared.

The Tung-B method was used under routine conditions with 33 participating technicians; the PEG method was performed at the research laboratory by several experienced technicians. As stated in the text, 406 samples (mean ± SD triglycerides 5.0 ± 6.7 mmol/L; cholesterol 7.1 ± 2.7 mmol/L) were analyzed, giving the following results: = 1.18 ± 0.45 mmol/L, = 1.19 ± 0.46 mmol/L; linear regression equation: y = (1.00 ± 0.01)x + (0.00 ± 0.01) mmol/L; r = 0.98, Sy|x = 0.030 mmol/L. In a separate series were analyzed 23 hyperlipidemic samples with triglycerides concentrations up to 10 mmol/L; these samples, which were twofold diluted with 40 g/L bovine serum albumin and eventually ultrafiltered, yielded the following results: = 0.59 ± 0.20 mmol/L, = 0.60 ± 0.18 mmol/L; linear regression equation: y = (0.92 ± 0.04)x + (0.04 ± 0.06) mmol/L; r = 0.96, Sy|x = 0.040 mmol/L.


   Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
For the second time we show that most first-generation HDL-chol methods are similarly accurate, except for the Tung-L method, which in our hands has a slight negative bias. The positive bias we obtained for the Hep method resulted from interference of Mn2+ in cholesterol determination with the CHOD-PAP reagent. This interference is absent when other cholesterol reagents are used, but in this study necessitated a blank determination for each sample (6) (the catalase cholesterol reagent we used in our earlier study is no longer available). However, as suggested in our previous work, the PEG 6000 method, coupled to cholesterol analysis with the CHOD-PAP reagent, emerged as a reliable method suitable for comparison purposes because of (a) its excellent agreement with the ultracentrifugation/Hep precipitation method, (b) its good agreement with density-gradient ultracentrifugation (17), (c) its precipitation efficiency in lipemic samples, and (d) our positive experience with this method in all our research projects in the last 15 years. Moreover, calibrating the Tung-B method against the PEG 6000 method fulfilled National Cholesterol Education Program criteria for accuracy and precision in comparison with the CDC HDL-chol method.

The HDL-chol determination necessarily consists of two steps: separation of the apolipoprotein B-containing lipoproteins from the HDL particles, followed by accurate and precise determination of the cholesterol in the HDL fractions. For many years our research and routine laboratories have participated in a national quality program designed to control the quality of total serum cholesterol determinations. Control sera are targeted on the basis of analysis with the certified Abell–Kendall method performed at the Lipid Reference Laboratory at Rotterdam (18). With this as a base for accuracy, we designed specific modifications so as to determine cholesterol at the low concentrations characteristic for HDL samples produced with either first- or second-generation precipitation methods. This involved simply increasing the ratio of sample to cholesterol reagent and diluting our primary calibrators. Irrespective of the absolute cholesterol concentration in the samples, precision was always satisfactory, at least if a proper sample/reagent ratio was selected.

Because of its greater precipitation efficiency, the Tung-B method is more generally applicable than the PEG 6000 method. The precipitation efficiency of the Dex method, a Proposed Selected Method and intended to be used as a "designated comparison method" in CDC HDL-chol standardization, is limited, however. Therefore, we suggest a broader application of the Tung-B method for standardization purposes.

Recently, "third-generation" HDL-chol methods have been introduced, in which no precipitation step is used (19)(20). Samples with triglyceride concentrations as great as 30 mmol/L can be analyzed without problems by using bichromatic analysis. Evaluations at higher triglyceride concentrations are scarce, although the results reported thus far are promising (19)(20)(21)(22). Such direct HDL analysis is efficient, but the reagent costs, including the disposable costs, are two- to threefold higher than with the Tung-B method. Moreover, the results by the Tung method are at least as good as those by the direct HDL method. The choice between both options is, therefore, a question of the motivation of the technicians and the available budget.


View this table:
[in this window]
[in a new window]
 
Table 3. Precipitation efficiency of the various HDL-chol precipitation methods.


   Acknowledgments
 
We thank C. Boersma Cobbaert (Lipid Reference Laboratory, Erasmus University, Rotterdam, The Netherlands) for performing the CDC HDL-chol analyses.


   Footnotes
 
1 Nonstandard abbreviations: chol, cholesterol; Hep, heparin/Mn2+; Tung-L, phosphotungstate/Mg2+ (Lopes-Virella version); Tung-B, phosphotungstate/Mg2+ (Boehringer version); Dex, dextran sulfate 50 000/Mg2+; PEG 6000, polyethylene glycol 6000; PEG/Dex, polyethylene glycol 6000/dextran sulfate 15 000; first- (second-) generation precipitation method, HDL assay performed with concentrated (diluted) precipitation reagent, resulting in concentrated (diluted) HDL samples; macro- and micromethods, cholesterol analysis under conditions optimal for cholesterol concentrations between 0.1 and 3.5 mmol/L or from 0.01 to 0.35 mmol/L, respectively; CDC, Centers for Disease Control and Prevention.


   References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Roads G, Gulbrandsen CL, Kagan A. Serum lipoproteins and coronary heart disease in a population of Hawaii Japanese men. N Engl J Med 1976;294:293-298. [Abstract]
  2. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SD, et al. HDL-cholesterol, other lipids in coronary heart disease. Circulation 1977;55:767-769. [Abstract/Free Full Text]
  3. Miller NE, Førde OH, Thelle DS, Mjos OD. The Tromso heart study: high-density lipoprotein and coronary heart disease, a prospective case-control study. Lancet 1977;i:9650-9668.
  4. . Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). J Am Med Assoc 1993;269:3015-3023. [Abstract/Free Full Text]
  5. Warnick GR, Benderson J, Albers JJ. Dextran sulfate–Mg2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982;28:1379-1388. [Free Full Text]
  6. Demacker PNM. Accuracy and precipitation efficiency of improved precipitation methods for quantifying high-density lipoprotein-cholesterol [Letter]. Clin Chem 1985;31:1768-1770. [Web of Science][Medline] [Order article via Infotrieve]
  7. McNamara JR, Huang C, Massov T, Teng Leary E, Warnick GR, Rubins HB, et al. Modification of the dextran–Mg2+ high-density lipoprotein precipitation method for use with previously frozen plasma. Clin Chem 1994;40:233-239. [Abstract/Free Full Text]
  8. Demacker PNM, Hijmans AGM, Vos-Janssen HE, van 't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high density lipoprotein. Clin Chem 1980;26:1775-1779. [Abstract/Free Full Text]
  9. Demacker PNM, Vos-Janssen HE, Hijmans AGM, van 't Laar A, Jansen AP. Measurement of high-density lipoprotein cholesterol in serum: comparison of six isolation methods combined with enzymatic cholesterol analysis. Clin Chem 1980;26:1780-1786. [Free Full Text]
  10. Burstein M, Scholnick HR. Lipoprotein–polyanion–metal interactions. Adv Lipid Res 1973;11:67-108. [Medline] [Order article via Infotrieve]
  11. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 1977;23:882-884. [Abstract/Free Full Text]
  12. Grove TH. Effect of reagent pH on determination of high-density lipoprotein cholesterol by precipitation with sodium phosphotungstate–magnesium. Clin Chem 1979;25:560-564. [Abstract/Free Full Text]
  13. Joern WA. Accurate preparation of solutions of hygroscopic salts: Mg2+ for high-density lipoprotein cholesterol assay [Letter]. Clin Chem 1979;25:639.[Web of Science][Medline] [Order article via Infotrieve]
  14. Baars JD, v d Harst P, Lombarts AJPF, de Kieviet W. Effective separation of HDL-cholesterol and LDL/VLDL cholesterol in sera with normal and elevated triglyceride concentrations. J Dutch Assoc Clin Chem 1989;14:1775-1779.
  15. Demacker PNM, van Oppenraay JBHA, Baadenhuijsen H, Jansen AP. An improved semi-automated method for the colorimetric determination of triglycerides in serum. Clin Chim Acta 1975;64:45-50. [Web of Science][Medline] [Order article via Infotrieve]
  16. Passing H, Bablock W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry. Part 1. J Clin Chem Clin Biochem 1983;21:709-720.
  17. Demacker PNM, van Sommeren-Zondag DF, Stalenhoef AFH, Stuyt PMJ, van 't Laar A. Ultracentrifugation in swinging bucket and fixed-angle rotors evaluated for isolation and determination of high-density lipoprotein subfractions HDL2 and HDL3. Clin Chem 1983;29:656-663. [Abstract/Free Full Text]
  18. Baadenhuijsen H, Demacker PNM, Hessels M, Boerma GJM, Penders ThJ, Weykamp C, Willems HL. Testing the accuracy of total cholesterol assays in an external quality-control program. Effect of adding sucrose to lyophilized control sera compared with use of fresh sera or frozen sera. Clin Chem 1995;41:724-730. [Abstract/Free Full Text]
  19. Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N, Miyauchi K. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated {alpha}-cyclodextrin. Clin Chem 1995;41:717-723. [Abstract/Free Full Text]
  20. Nauck M, März W, Haas B, Wieland H. Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated. Clin Chem 1996;42:424-429. [Abstract/Free Full Text]
  21. Harris N, Galpchian V, Rifai N. Three routine methods for measuring high-density lipoprotein cholesterol compared with the Reference Method. Clin Chem 1996;42:738-743. [Abstract/Free Full Text]
  22. Jarausch J, Assmann G, Bernard D, Cobbaert C, Delanghe J, von Eckardstein A, et al. Evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment. Internal communication, Boehringer Mannheim 1996;.



The following articles in journals at HighWire Press have cited this article:


Home page
CirculationHome page
C. G. Magnussen, O. T. Raitakari, R. Thomson, M. Juonala, D. A. Patel, J. S.A. Viikari, J. Marniemi, S. R. Srinivasan, G. S. Berenson, T. Dwyer, et al.
Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood: Evidence From the Childhood Determinants of Adult Health (CDAH) Study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study
Circulation, January 1, 2008; 117(1): 32 - 42.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Popa, M G Netea, T Radstake, J W M Van der Meer, A F H Stalenhoef, P L C M van Riel, and P Barerra
Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis
Ann Rheum Dis, February 1, 2005; 64(2): 303 - 305.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
K. Kaneko, R. Ueda, T. Kawata, S. Ishizaka, and T. Yoshimura
LPS binding protein does not participate in the pharmacokinetics of E5564
Innate Immunity, June 1, 2004; 10(3): 185 - 194.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. de Roos, M. J Caslake, A. F. Stalenhoef, D. Bedford, P. N. Demacker, M. B Katan, and C. J Packard
The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects
Am. J. Clinical Nutrition, January 1, 2001; 73(1): 45 - 52.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. M. W. M. te Loo, L. A. H. Monnens, T. J. A. M. van der Velden, M. A. Vermeer, F. Preyers, P. N. M. Demacker, L. P. W. J. van den Heuvel, and V. W. M. van Hinsbergh
Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome
Blood, June 1, 2000; 95(11): 3396 - 3402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. J van Tits, P. N Demacker, J. de Graaf, H. L Hak-Lemmers, and A. F Stalenhoef
{alpha}-Tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals1
Am. J. Clinical Nutrition, February 1, 2000; 71(2): 458 - 464.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Cobbaert, P. G.H. Mulder, H. Baadenhuijsen, L. Zwang, C. W. Weykamp, and P. N.M. Demacker
Survey of Total Error of Precipitation and Homogeneous HDL-Cholesterol Methods and Simultaneous Evaluation of Lyophilized Saccharose-containing Candidate Reference Materials for HDL-Cholesterol
Clin. Chem., March 1, 1999; 45(3): 360 - 370.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Nauck, W. Marz, and H. Wieland
New immunoseparation-based homogeneous assay for HDL-cholesterol compared with three homogeneous and two heterogeneous methods for HDL-cholesterol
Clin. Chem., July 1, 1998; 44(7): 1443 - 1451.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demacker, P. N. M.
Right arrow Articles by Baadenhuijsen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demacker, P. N. M.
Right arrow Articles by Baadenhuijsen, H.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS